ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Amsterdam UMC at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Amsterdam UMC takes part in 16 sessions at ESMO 2026 in Madrid. Its program centres on gastrointestinal cancer treatment and outcomes, alongside research on metastatic disease. Topics include when to use local treatment for metastatic oesophageal or gastric cancer and how tumour volume may help define colorectal cancer spread to the liver.
| Organization | ESMO 2026 Attendance |
|---|---|
Amsterdam UMC Amsterdam, Netherlands | |
University medical centre of the University of Amsterdam and Vrije Universiteit Amsterdam, in Amsterdam, Netherlands. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Prevalence, histopathological and clinical characteristics of POU2F3-positive tuft cell-like small-cell and non-small cell lung carcinoma's Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Timing of minimally invasive local treatment after first-line systemic therapy in oligometastatic esophageal or gastric adenocarcinoma: The OMEC-5 phase II study Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 Satellite Fri Oct 23 18:15–19:45 Satellite Fri Oct 23 18:15–18:20 Welcome and introductions Genitourinary cancers Satellite Fri Oct 23 19:00–19:40 Chair Sat Oct 24 08:30–10:00 Optimising personalised care for gastroesophageal cancer Gastrointestinal cancers Talk Sat Oct 24 09:30–09:50 Optimising treatment for elderly and comorbid patients Gastrointestinal cancers Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Incidence of opioid-induced constipation: A systematic review and meta-analysis Nursing & supportive care Chair Sun Oct 25 10:15–11:45 Proffered paper 1: NSCLC, metastatic Lung & thoracic cancers Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Mismatch repair testing and prognostic implications in gastroesophageal adenocarcinoma: A population-based study Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Talk Sun Oct 25 17:00–17:15 Is consolidative treatment needed in case of a clinical complete response? Genitourinary cancers Satellite Mon Oct 26 13:00–14:30 AstraZeneca - Advancing clinical practice and patient care in gastroesophageal cancer Gastrointestinal cancers Satellite Mon Oct 26 13:00–13:05 Welcome and introductions Gastrointestinal cancers Satellite Mon Oct 26 13:05–13:25 Plenary: The emerging standard: optimising clinical practice for resectable GC / GEJC Gastrointestinal cancers Satellite Mon Oct 26 13:25–13:30 Audience Q&A Gastrointestinal cancers Satellite Mon Oct 26 13:50–14:20 Satellite Mon Oct 26 14:20–14:25 Audience Q&A Gastrointestinal cancers Satellite Mon Oct 26 14:25–14:30 Close Gastrointestinal cancers Talk Mon Oct 26 15:10–15:35 Pushing boundaries with local therapies: Maximizing patient outcomes and recognizing limitations Gastrointestinal cancers Chair Mon Oct 26 16:30–18:00 Resectable early stage NSCLC Lung & thoracic cancers |
Find decision makers at Amsterdam UMC
Tell us what you sell and we’ll find the people at Amsterdam UMC most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction